Immunogenomic profiling further illuminated the broad impact of RAC1 upregulation on immune checkpoint molecules, tumor infiltrating lymphocytes, and neoantigen loads, suggesting a complex interplay between RAC1‐driven oncogenic signaling and immune surveillance mechanisms. Here, RAC1 is linked to neoplasm.